JAZZ

JAZZ

USD

Jazz Pharmaceuticals plc Common Stock (Ireland)

$110.800+2.280 (2.101%)

リアルタイム価格

Healthcare
バイオテクノロジー
アイルランド

価格チャート

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$108.520

高値

$111.170

安値

$107.660

出来高

0.22M

企業ファンダメンタルズ

時価総額

6.7B

業種

バイオテクノロジー

Ireland

取引統計

平均出来高

1.15M

取引所

NMS

通貨

USD

52週レンジ

安値 $95.49現在値 $110.800高値 $148.06

関連ニュース

PR Newswire

Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...

もっと見る
Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer
PR Newswire

Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company, along with its partners, will present seven abstracts at the American...

もっと見る
Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma
PR Newswire

Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 first quarter financial results on Tuesday, May 6, 2025, after...

もっと見る
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025
PR Newswire

Jazz Pharmaceuticals Completes Acquisition of Chimerix

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz" or the "Company") today announced the successful completion of its acquisition of Chimerix, Inc....

もっと見る
Jazz Pharmaceuticals Completes Acquisition of Chimerix
Analyst Upgrades

Needham Reiterates Buy on Jazz Pharmaceuticals, Maintains $210 Price Target

Needham analyst Ami Fadia reiterates Jazz Pharmaceuticals with a Buy and maintains $210 price target.

もっと見る
Needham Reiterates Buy on Jazz Pharmaceuticals, Maintains $210 Price Target